T1	Participants 77 119	patients with breast and colorectal cancer
T2	Participants 546 591	cancer during adjuvant chemotherapy treatment
T3	Participants 827 918	patients with breast cancer (BRCA) and colorectal cancer (CRC) during adjuvant chemotherapy
